東北大学大学院医学系研究科・医学部

STAFF

Professor

• Fukuhara, TatsuroProfessor. 福原 達朗 教授

CONTACT

OUTLINE

Our laboratory is located at Miyagi Cancer Center and focuses on lung cancer research. While closely related to lung cancer treatment at the hospital, we will carry out basic research in collaboration with each laboratory of the institute. We are collaborating with the Department of Respiratory Medicine, Tohoku University Graduate School of Medicine.

当研究室は、宮城県立がんセンターにあり、肺癌研究を主とします。病院で肺癌診療と密に関わりながら、研究所の各教室と連携し基礎研究を行います。東北大学　内科病態学講座　呼吸器内科学分野の連携講座です。

ARTICLE

Kobayashi M, et al. MK-6, a novel not-α IL-2, elicits a potent antitumor activity by improving the effector to regulatory T cell balance. Cancer Sci. 2021 Sep 20.
doi: 10.1111/cas.15127.
URL：https://onlinelibrary.wiley.com/doi/abs/10.1111/cas.15127

Fukuhara T, et al. Evaluation of plasma EGFR mutation as an early predictor of response of erlotinib plus bevacizumab treatment in the NEJ026 study. EBioMedicine. j.ebiom. 102861. 2020.
URL：https://www.thelancet.com/journals/ebiom/article/PIIS2352-3964(20)30236-X/fulltext

Morita M, et al. PKM1 Confers Metabolic Advantages and Promotes Cell-Autonomous Tumor Cell Growth. Cancer Cell. Mar 12;33(3):355-367.e7. 2018
URL：https://www.cell.com/cancer-cell/fulltext/S1535-6108(18)30057-6

Fukuhara T, et al. Factors associated with a poor response to gefitinib in the NEJ002 study: smoking and the L858R mutation. Lung Cancer. 2015 May;88(2):181-6.
URL：https://linkinghub.elsevier.com/retrieve/pii/S0169-5002(15)00090-2

Jan Treda C, et al. Secretory leukocyte protease inhibitor modulates urethane-induced lung carcinogenesis. Carcinogenesis.; 35(4):896-904. 2014
URL：https://academic.oup.com/carcin/article/35/4/896/269177